#roche

3 stories

#alk7 #baloxavir marboxil #biotech firm #chronic disease burden #fidson healthcare plc #finance #generic medicine #global healthcare #global licence #glp-1 #health security #healthcare infrastructure

Roche Bets $1.16 Billion on RNAi Weight-Loss Therapy
Roche secures $1.16 billion RNAi weight-loss drug deal with Rona Therapeutics.
BigGo Finance · 1m
Roche Calls for Global Healthcare Overhaul
Roche urges global healthcare reform to address rising chronic disease burden.
The Economic Times · 1m
Nigerian Drugmaker Fidson Selected for Global Influenza Antiviral
Nigerian firm Fidson Healthcare Plc joins global effort to produce generic influenza antiviral under Roche-MPP license.
Allafrica · 1m